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In humans, DOCK8 immunodeficiency syndrome is characterized by severe cutaneous viral 
infections. Thus, CD8 T cell function may be compromised in the absence of DOCK8. In  
this study, by analyzing mutant mice and humans, we demonstrate a critical, intrinsic role  
for DOCK8 in peripheral CD8 T cell survival and function. DOCK8 mutation selectively 
diminished the abundance of circulating naive CD8 T cells in both species, and in  
DOCK8-deficient humans, most CD8 T cells displayed an exhausted CD45RA+CCR7 pheno-
type. Analyses in mice revealed the CD8 T cell abnormalities to be cell autonomous and 
primarily postthymic. DOCK8 mutant naive CD8 T cells had a shorter lifespan and, upon 
encounter with antigen on dendritic cells, exhibited poor LFA-1 synaptic polarization and a 
delay in the first cell division. Although DOCK8 mutant T cells underwent near-normal 
primary clonal expansion after primary infection with recombinant influenza virus in vivo, 
they showed greatly reduced memory cell persistence and recall. These findings highlight  
a key role for DOCK8 in the survival and function of human and mouse CD8 T cells.
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tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
Share  Alike  3.0  Unported  license,  as  described  at  http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
CD8 T cells have a remarkable capacity for 
clonal expansion and play an important role in 
immunity (Masopust et al., 2007). Their essential 
role  in  immunity  has  been  demonstrated  in 
mice by genetic or antibody-mediated ablation 
studies (Doherty, 1996; Harty et al., 2000) and 
is evidenced in humans by chronic sinopulmo-
nary infections in rare individuals with selective 
CD8 T cell deficiency caused by homozygous 
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range (Engelhardt et al., 2009; Zhang et al., 2009). In vitro 
stimulation with antibodies to CD3 and CD28 found that 
CD8 T cells from patients exhibited little or no proliferation 
compared with healthy controls, whereas CD4 T cell re-
sponses were diminished in some patients but relatively nor-
mal in others (Engelhardt et al., 2009; Zhang et al., 2009). 
However, it is unclear to what extent these effects are pri-
mary consequences of DOCK8 deficiency in CD8 T cells or 
secondary  to  the  multiple,  recurrent  infections  afflicting 
DOCK8-deficient patients or their treatment. For example, 
responses have yet to be measured in CD8 T cells fraction-
ated with respect to the various naive and memory subsets. 
The concurrent discovery of Dock8 mutant mice provides an 
opportunity to compare the consequences of DOCK8 defi-
ciency in T cells from both species, taking advantage of spe-
cific pathogen-free conditions and cell mixing experiments 
in mice to exclude confounding factors of humoral immuno-
deficiency and concurrent infections.
In this study, we show that DOCK8 acts cell autono-
mously in CD8 T cells and that its deficiency causes pro-
found  qualitative  abnormalities  in  mice  and  humans.  In 
humans, the most striking effect is depletion of circulating 
naive CD8 T cells and accumulation of an exhausted subset 
of CD8 T cells that are unresponsive to CD3/CD28 stimula-
tion. In mice, the most striking effect is a failure of memory 
CD8 T cells to persist and mount a recall response after the 
first wave of CD8 T cell proliferation after influenza infec-
tion. The selective failure of memory CD8 T cell persistence 
parallels the effects of other mutations that affect LFA-1 or 
TCR concentration at the T cell synapse during initial anti-
gen encounter, and those parallels are borne out here by 
demonstrating that DOCK8 deficiency diminishes recruit-
ment of LFA-1 to the CD8 T cell synapse with DCs. These 
results extend and translate to human immunity evidence for 
an  intimate  relationship  between  the  quality  of  the  CD8   
T cell immune synapse and the generation of long-lived, re-
callable memory CD8 T cells.
RESULTS
Altered differentiation and impaired proliferation of T cells 
from DOCK8-deficient humans
To explore the effects of DOCK8 deficiency on T cells, we 
first analyzed peripheral blood T cells from six DOCK8- 
deficient patients from five unrelated kindreds. Some of the 
clinical characteristics of these patients are detailed in Table I. 
Consistent with a previous study (Engelhardt et al., 2009), 
the frequency of CD8 T cells within the total lymphocyte 
population from DOCK8-deficient patients was comparable 
with that of normal age-matched controls (Fig. 1, A and B). 
However, when subsets of CD8 T cells were enumerated, 
there  was  a  dramatic  and  highly  significant  loss  of  naive 
(CD45RA+CCR7+) cells (10% in patients compared with 
45% in normal controls), together with a smaller but still 
significant decrease in memory (CD45RACCR7/+) CD8 
T cells. Strikingly, the majority of CD8 T cells from DOCK8-
deficient patients exhibited a CD45RA+CCR7 phenotype 
mutations in CD8, TAP1, or TAP2 (de la Salle et al., 1999; 
Gadola et al., 2000; de la Calle-Martin et al., 2001) or by the 
reconstitution of immunity to EBV and CMV with CD8   
T cells during transplantation (Walter et al., 1995). A key 
question in the field is how CD8 T cell differentiation into 
short-lived cytotoxic effector T cells is balanced against main-
taining a persisting pool of CD8 memory T cells with potent 
recall responses to avoid exhausting the pool of responding   
T cells and how failure of this process may contribute to 
chronic viral illness (Intlekofer et al., 2006; Williams et al., 
2006a; Sallusto et al., 2010). Answers to this question hold 
the potential for new interventions to promote long-lived 
CD8 T cell immunity in vaccination or chronic infection but 
require experimental studies that bridge human and mouse 
memory CD8 T cells.
The recent discovery of an immunodeficiency syndrome 
caused by inactivating mutations in DOCK8 in humans and 
mice (Engelhardt et al., 2009; Randall et al., 2009; Zhang   
et al., 2009) provides a unique opportunity to analyze the 
consequences  of  this  specific  molecular  perturbation  for 
CD8 T cells in both species. DOCK8 is a member of the 
DOCK family of intracellular signaling proteins, which are 
recruited  to  PIP3  (phosphatidylinositol-trisphosphate)-rich 
membranes through their DHR1 (Dock homology region 1) 
domain and serve as guanine exchange factors for Rho/
Rac family GTPases through their DHR2 domain (Côté 
and Vuori, 2007). Other members of this protein family are 
involved in polarized accumulation of cell adhesion mole-
cules and actin filaments required for cell adhesion, migra-
tion, and signaling events (Côté and Vuori, 2007). DOCK8 
is most highly expressed in B and T lymphocytes. Individuals 
with homozygous inactivating DOCK8 mutations present 
with clinical signs of combined B and T cell immunodefi-
ciency: recurrent sinopulmonary infections typical of humoral 
immunodeficiency and severe cutaneous viral infections with 
HSV, human papillomavirus (HPV), and scarring Molluscum 
contagiosum suggestive of T cell dysfunction (Engelhardt et al., 
2009; Zhang et al., 2009). These patients also have severe   
atopy with almost universal atopic dermatitis and sensitization   
to both foods and aeroallergens. It is likely that DOCK8   
mutations account for most of the patients previously classi-
fied  as  having  autosomal  recessive  hyper-IgE  syndrome 
(HIES  [AR-HIES];  Engelhardt  et  al.,  2009).  Analysis  of 
DOCK8-deficient  mice  has  shown  that  mutations  in  this 
gene cause a partial humoral immunodeficiency, affecting   
B cells autonomously to prevent long-lasting serum antibody 
production  after  immunization.  DOCK8-deficient  B  cells 
lack normal recruitment of ICAM-1 to the B cell immune 
synapse, are unable to form marginal zone B cells, and have 
greatly reduced persistence and affinity maturation of germi-
nal center B cells (Randall et al., 2009).
In contrast, little is known about the effects of DOCK8 
deficiency  within  the  T  cell  lineage  in  humans  or  mice. 
Moderate decreases in circulating T cell numbers have been 
found in some human DOCK8-deficient patients, although 
in many others the CD8 T cell count was within the normal JEM Vol. 208, No. 11 
Article
2307
T  cell  compartment  toward  exhausted  TEMRA  cells  in 
DOCK8 deficiency reveals a separate effect that compli-
cates interpretation of the role of DOCK8 in human CD8   
T cell proliferation.
In contrast to the striking shift in CD8 T cell phenotypic 
subsets, when the CD4 T cell compartment of DOCK8-
deficient patients was examined, although there was a signifi-
cant reduction in the frequency of CD4 T cells within the 
lymphocyte population, we found that the distribution of 
naive (CD45RA+CCR7+) and memory (CD45RACCR7/+) 
subsets  in  DOCK8-deficient  patients  resembled  that  ob-
served for normal controls (Fig. 1, D and E). Despite this, 
functional analysis of naive and memory CD4 T cells from 
patients 1 (Fig. 1 F) and 2 (Fig. 1 G) revealed markedly di-
minished  proliferation  after  stimulation  with  TAE  beads 
compared with the vigorous division of corresponding CD4 
T cell subsets from normal donors. Furthermore, although 
division of the mutant DOCK8 T cells could be improved by 
exogenous IL-2, it remained substantially less than that of 
control cells (Fig. 1, F and G). Thus, DOCK8 deficiency 
in humans diminishes clonal expansion of both CD4 and 
CD8 T cells in response to engagement of TCR and co-
stimulatory molecules.
CD8+ T cells in DOCK8-deficient patients have undergone 
chronic activation in vivo
TEMRA cells have been found to have experienced exten-
sive replication in vivo (Hamann et al., 1999; Dunne et al., 
2002;  Rufer  et  al.,  2003)  yet  exhibit  poor  proliferation   
in vitro (Champagne et al., 2001; Geginat et al., 2003).   
(Fig. 1, A and B), which is typically associated with cell ex-
haustion or replicative senescence (Appay et al., 2008). Be-
cause of their reexpression of CD45RA, these cells have 
been termed effector memory CD45RA+ (TEMRA) cells.
For functional analyses, CD8 T cells from the different pa-
tients were sorted into populations of either naive (CD45RA+ 
CCR7+), memory (CD45RACCR7/+), or TEMRA (CD45RA+ 
CCR7) cells, labeled with CFSE, and stimulated with T cell 
activation and expansion (TAE) beads, which were coated 
with mAb to human CD3, CD28, and CD2, in the absence 
or presence of IL-2. Because of the lymphopenia that is charac-
teristic of DOCK8-deficient patients (Zhang et al., 2009), 
not all subsets of these cells could be recovered in sufficient 
numbers from all patients. Consequently, the data presented 
in Fig. 1 C are a composite derived from experiments per-
formed using subsets of CD8 T cells isolated from different 
patients. Naive (CD45RA+CCR7+) and memory (CD45RA 
CCR7/+) CD8 T cells from normal controls were induced 
to undergo multiple rounds of division in response to stimu-
lation with TAE beads, whereas the corresponding subset 
from DOCK8-deficient patients failed to divide under these 
stimulatory conditions (Fig. 1 C). Notably, provision of ex-
ogenous IL-2 failed to improve proliferation of DOCK8-
deficient memory cells (Fig. 1 C). In contrast, there was an 
absence of a proliferative response by TEMRA cells from either 
normal donors or patients (Fig. 1 C). This is consistent with 
previous findings that have investigated the CD8 TEMRA cell 
subset from normal donors as well as in other clinical settings 
(Champagne et al., 2001; Brenchley et al., 2003; Geginat   
et al., 2003; Papagno et al., 2004). The shift of the CD8   
Table I.  DOCK8-deficient patients
DOCK8-deficient 
patients
Age at analysis DOCK8 mutation Effect on protein Clinical features
yr
#1 14 Homozygous 114-kb deletion 
spanning exons 4–26
Not expressed Pneumonia, eczema, cutaneous lesions, 
fungal infections, eosinophilia;  
IgE 4,800–10,000 IU/ml
#2 (patient ARH012; 
Engelhardt et al., 
2009)
12 Homozygous A→T mutation 
position 70 in exon 7
Premature stop codon: 
K271X
Severe M. contagiosum, pneumonia, 
meningitis, eczema; IgE 10,000 IU/ml
#3 4 Homozygous 150-kb deletion Not expressed M. contagiosum infection (family history)
#4 10 Large homozygous deletion Not expressed Recurrent otitis media, eczema, HPV, 
onychomycosis, Salmonella;  
IgE 1,552 IU/ml; suggestive inflammatory 
bowel disease and vasculitis
#5 11 Large homozygous deletion Not expressed Recurrent upper respiratory tract infection, 
HPV, Giardia lamblia, Salmonella;  
IgE 19,302 IU/ml; inflammatory bowel 
disease and vasculitis
#6 12 c.3733_3734delAG Premature stop codon: 
p.R1245EfsX5
Eczema (with methicillin-resistant S. aureus 
infection), M. contagiosum, recurrent otitis 
media (methicillin-resistant S. aureus), 
multiple food allergies; IgE 1,500 IU/ml
Patients #4 and #5 are siblings.2308 DOCK8 deficiency cripples CD8 T cells | Randall et al.
not only acquire expression of CD57, but also dramatically 
up-regulate CD244 (2B4), CD11a, CD11b, CX3CR1, CD95, 
and granzyme B and concomitantly down-regulate CD27, 
CD28, and CD127 (IL-7R; Fig. 2 and Fig. S1). Notably, 
expression of these molecules is substantially increased (CD244, 
CD11a, CD11b, CD57, CX3CR1, CD95, and granzyme B) 
or decreased (CD27, CD28, and CD127) on normal TEMRA 
cells (Fig. 2 and Fig. S1). Remarkably, the levels of ex-
pression of these molecules on memory CD8 T cells from 
DOCK8-deficient  patients  resembled  that  of  TEMRA  cells 
from normal individuals (Fig. 2 and Fig. S1). Indeed, unlike 
normal memory and TEMRA cells, there was no significant 
difference in their levels of expression between DOCK8-
deficient memory CD8 T cells and normal TEMRA cells (Fig. 2 
and  Fig.  S1).  Furthermore,  these  molecules  were  up-  or 
Furthermore, in the setting of chronic viral infection, these 
cells may have undergone replicative senescence (Chen et al., 
2001; Brenchley et al., 2003; Papagno et al., 2004; Plunkett   
et al., 2005). A feature of the TEMRA cell population is expres-
sion  of  CD57  on  a  substantial  proportion  of  these  cells   
(Appay et al., 2008). Interestingly, CD57 expression corre-
lates with both an inability to undergo proliferation in re-
sponse to either polyclonal or antigen-specific stimulation 
and heightened susceptibility to apoptosis in vitro (Brenchley 
et  al.,  2003).  To  further  analyze  CD8  T  cell  subsets  in 
DOCK8 deficiency and to understand the proliferative de-
fects in these cells, we assessed expression of a range of mole-
cules whose expression is altered during differentiation of 
naive cells into effector cells (Appay et al., 2008). Compared 
with naive cells, memory CD8 T cells from normal donors 
Figure 1.  DOCK8 deficiency severely perturbs differentiation and proliferation of naive and memory human T cells. PBMCs from normal  
donors or DOCK8-deficient patients were analyzed. (A and B) Representative FACS plots and quantitation of total CD8 T cells and naive (CD45RA+CCR7+), 
memory (CD45RACCR7), and TEMRA (effector memory CD45+ [CD45RA+CCR7]) cell subsets. The FACS plots in A show one representative normal donor 
and one DOCK8-deficient patient, whereas the graphs in B show data for all samples analyzed, with the horizontal bars representing the mean frequency 
of cells with the indicated phenotype. (C) CD8 naive, memory, and TEMRA T cells were isolated from normal donors and patients 1 and 2 (red histograms), 
labeled with CFSE, and then stimulated with TAE beads in the absence or presence of exogenous IL-2. Cell division was determined after 5 d by measuring 
dilution of CFSE. (D and E) Representative FACS plots and quantitation of total CD4 T cells and naive (CD45RA+CCR7+), memory (CD45RACCR7), and 
TEMRA (CD45RA+CCR7) cell subsets. The FACS plots in D show one normal donor and one DOCK8-deficient patient, whereas the graphs in E show data for 
all samples analyzed, with the horizontal bars representing the mean frequency of cells with the indicated phenotype. (F and G) CD4+ naive (left) and 
memory (right) T cells were isolated from normal donors and patients 1 (F) and 2 (G; red histograms), labeled with CFSE, and then stimulated with TAE 
beads in the absence of presence of exogenous IL-2. Cell division was determined after 5 d by measuring dilution of CFSE. Significant differences were 
determined by the Student’s t test.JEM Vol. 208, No. 11 
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CD8 T cells have undergone aberrant differentiation in vivo, 
such that most non-naive cells have acquired an effector/ 
exhausted  phenotype,  whereas  naive  cells  exhibit  features   
of early activation.
Intrinsic effects of DOCK8 deficiency on circulating  
naive CD8 T cells
The cell-autonomous role of DOCK8 in T cells was further 
investigated in specific pathogen-free C57BL/6 mice homo-
zygous for the inactivating Dock8pri/pri mutation. These ani-
mals inherit a Ser>Pro substitution predicted to disrupt a key 
-helix in the Rho/Rac-binding site of the DHR2 domain and 
have a comparable phenotype with Dock8cpm/cpm 
mice  homozygous  for  a  truncating  mutation 
that abolishes over half of the protein (Randall   
et al., 2009). We first sought to understand   
the depletion of naive CD8 T cells in human 
DOCK8 deficiency by focusing on the forma-
tion  and  numbers  of  circulating  naive  CD8   
T cells in Dock8pri/pri mice.
Paralleling  the  human  phenotype,  the   
number of circulating naive CD8 T cells was 
decreased  in  Dock8pri/pri  homozygous  mutants   
(Fig. 3, A and B). CD8 and CD4 T cell subsets 
were  subdivided  into  naive  and  activated/
memory cells by flow cytometric staining for 
CD44.  Naive  CD44lo  T  cell  subsets  within 
both  CD8  and  CD4  populations  were  de-
creased 50% in blood, spleen, and LNs of 
Dock8pri/pri mice (Fig. 3, A and B; and Fig. S2).   
In contrast, the percentages and numbers of   
activated/memory  CD44hi  CD8  and  CD4   
T cells were comparable or slightly increased in 
DOCK8 mutant animals. Further analysis of   
the expression of CD45RB, PD-1, CTLA-4, 
KLRG1, CD127, CD122, CD25, CD27, CD3, 
or Tbet on the CD8+CD44hi subset revealed no 
difference  in  Dock8pri/pri  mice  compared  with 
normal controls (Fig. S3). Parallel analyses of 
Dock8cpm/cpm mice yielded comparable results 
(Figs.  S3  and  S4).  These  data  indicate  that 
DOCK8 deficiency in specific pathogen-free 
mice also diminishes naive CD8 cells, but in 
down-regulated  to  a  greater  extent  on  DOCK8-deficient 
TEMRA CD8 T cells compared with corresponding cells from 
normal donors (Fig. 2 and Fig. S1). Thus, the vast majority 
(>70%) of DOCK8-deficient TEMRA CD8 T cells exhibited 
a CD57+CX3CR1+CD27CD28CD127 phenotype, com-
pared with only 40–50% of normal TEMRA cells which had 
this phenotype (Fig. 2). Remarkably, even naive CD8 T cells 
from  DOCK8-deficient  patients  differed  phenotypically 
from normal naive cells inasmuch that they expressed ele-
vated levels of CD11a, CD11b, and CD95 and displayed a mild 
down-regulation of CD28, CD27, and CD127 (Fig. 2 and 
Fig. S1). Overall, these data suggest that DOCK8-deficient 
Figure 2.  Phenotypic analysis of human DOCK8-
deficient CD8+ T cells. (A–E) PBMCs from normal  
donors (n = 9) or DOCK8-deficient patients (n = 4) were 
labeled with anti-CD8, anti-CD45RA, and anti-CCR7 
mAbs and either isotype control or mAb specific for 
CD28, CD57, CD95, CD127 (IL-7Ra), and CX3CR1. The 
expression of these molecules on naive (CD45RA+CCR7+), 
memory (CD45RACCR7), and TEMRA (CD45RA+CCR7) 
cell subsets of CD8 T cells was then determined. The  
histogram plots are from one representative normal donor 
or control. Each value in the graphs corresponds to an 
individual normal donor or patient; the horizontal bars 
represent the mean.2310 DOCK8 deficiency cripples CD8 T cells | Randall et al.
observed in animals with defective thymic egress (Matloubian 
et al., 2004; Carlson et al., 2006; Shiow et al., 2008). More-
over, when the Dock8pri/pri mutation was crossed into trans-
genic mice expressing an MHC I–restricted TCR, OT-I,   
it caused no discernable decrease in the positive selection 
of  CD8  single-positive  T  cells  bearing  this  TCR  (Fig.  3,   
E and F).  Interestingly,  the  frequency  of  naive  peripheral 
CD8 T cells bearing the OT-I TCR was unaffected by the 
Dock8pri/pri mutation. Collectively, these results indicate that 
DOCK8  deficiency causes only subtle changes in thymic   
T cell differentiation.
The decrease in naive peripheral CD8 and CD4 T cells 
could  reflect  either  a  cell-autonomous  requirement  of 
DOCK8 in these T cell subsets or a secondary effect of ab-
normalities in other cell types. To distinguish between these 
alternatives, we constructed mixed bone marrow chimeras by 
reconstituting irradiated mice with 50:50 mixtures of con-
genically marked bone marrow from Dock8pri/pri CD45.2 and 
Dock8+/+ CD45.1 donors. Peripheral B220+ cells were re-
constituted in almost equal ratios by mutant and WT cells, con-
sistent with previous results demonstrating no effect of the 
mutation on circulating B cell numbers (Randall et al., 2009) 
and thereby providing an internal measure for relative en-
graftment by the two marrow sources in each chimeric animal 
(reconstitution of individuals shown by bars in Fig. 4 A). In 
contrast, CD45.2+ T cells with defective DOCK8 were dra-
matically  underrepresented  in  peripheral  CD8  and  CD4   
T cell subsets so that they comprised only 5% of circulating   
T cells on average. In the same animals, DOCK8 mutant T cells 
averaged  16%  of  thymic  CD4  and  CD8  single-positive   
T cells, 22% of CD4+CD8+ double-positive cells, and 30%   
of CD4CD8 double-negative cells. The proportion of 
peripheral CD45.2+ CD8 T cells that were CD44hi in the 
mixed chimeras was not elevated, comprising 20% of 
Dock8pri/pri CD8 cells and 18% of Dock8+/+ CD8 cells (Fig. 4 B). 
Collectively, these results indicate that DOCK8 deficiency 
has a subtle cell-autonomous effect on T cells that is com-
pounded  at  progressive  stages  of  thymic  and  peripheral   
T cell formation.
To investigate further the decreased number of naive 
peripheral CD8 T cells, we adoptively transferred mixtures of 
congenically marked normal and Dock8pri/pri mutant spleen   
T cells into normal C57BL/6 mice. The survival of these 
adoptively transferred T cells was then determined by assess-
ing the total number of adoptively transferred cells present as 
well as the ratio of WT to mutant donor-derived T cells at 
various time points compared with their ratios at the time of 
injection. Both WT and mutant T cells slowly declined in 
frequency up to 39 d after adoptive transfer (Fig. 5, A and B). 
The contribution of mutant T cells as a percentage of total 
donor T cells was consistently lower than the input percent-
age. Similar results were obtained when the transferred WT 
and Dock8pri/pri T cells were obtained from OT-I TCR trans-
genic mice with a homogeneous TCR specificity: mutant 
OT-I T cells accounted for 39% of the OT-I cells at the time 
of transfer but only 20% after 39 d, representing a halving of 
this situation it does not result in accumulation of exhausted 
memory CD8 T cells.
Decreased naive CD8 or CD4 T cells in the periphery of 
Dock8pri/pri mice was not explained by any consistent decrease 
in the numbers of CD8 or CD4 single-positive T cells in the 
thymus (Fig. 3 C). In some experiments, there were slightly 
fewer CD4 and CD8 T cells in the thymus of Dock8pri/pri mice 
(Fig. S5 A), although this was not consistently observed. 
Further subsetting of mature CD4 and CD8 thymocytes 
based on expression of CD62L and CD69 revealed slightly 
decreased  frequencies  of  less  mature  CD69hiCD4+  and   
CD69hiCD8+ cells in Dock8pri/pri thymi as a percentage of the 
total lymphocytes (Fig. 3 D). There was no consistent evidence 
for accumulation or deficiency of mature CD62L+CD69 
single-positive cells (Fig. 3 D and Fig. S5) in the thymus as is 
Figure 3.  Analysis of T cells in Dock8pri/pri mice. (A) Representative 
flow cytometry plots of T cells in the spleen of Dock8pri/pri and C57BL/6 
(+/+) mice. (B–D) Quantitation of T cells in spleen (B) and various subsets 
of thymic T cells (C and D) for age-matched C57BL/6 and Dock8pri/pri mice. 
Bars are means, error bars indicate SEM, and dots indicate individual mice. 
Statistical analysis was performed by the unpaired Student’s t test with 
Welch’s correction. Data are representative of three independent experi-
ments. (E) Representative flow cytometry plots of thymic (top) and splenic 
(bottom) cells from OT-I mice. (F) Quantitation of thymic and splenic CD8 
T cells in WT and mutant OT-I mice. Bars are medians, and dots indicate 
individual mice.JEM Vol. 208, No. 11 
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between the mutant and WT cells. Addition of 
exogenous IL-2 did not rectify the delayed first 
division of DOCK8 mutant T cells (not de-
picted).  In  vitro  activated  Dock8pri/pri  CD8 
OT-I  cells  had  normal  cytotoxic  activity  in 
chromium release assays (Fig. S8), and normal 
TNF,  IFN-,  and  IL-2  were  produced  by 
Dock8pri/pri CD8 cells in response to PMA and 
ionomycin (not depicted). DOCK8-deficient nontransgenic 
T cells divided almost normally in response to anti-CD3 and 
CD28 antibodies, although there was again evidence of a 
slight decrease (not depicted).
To  investigate  earlier  steps  in  CD8  T  cell  activation, 
DOCK8 mutant and WT naive OT-I T cells were purified 
and co-cultured with SIINFEKL-pulsed DCs as above, and 
cell conjugates formed after 1 h were fixed and immunofluo-
rescently labeled. Polarization of the microtubule-organizing 
center (MTOC; identified by tubulin staining) to the T cell–
DC interface was used as a marker of immunological synapse 
formation. Images were obtained by confocal microscopy, 
and the polarization of proteins important for immune syn-
apse formation was scored, with 3 indicating that the protein 
of interest was highly polarized to the T cell/DC interface,   
0 indicating no polarization, and 3 indicating that the protein 
of interest was highly polarized away from the T cell–DC inter-
face. LFA-1 was highly polarized to the immune synapse of 
WT OT-I T cells, whereas Dock8pri/pri OT-I T cells mostly 
showed an even distribution of LFA-1 on the cell surface, in-
dicating a failure of LFA-1 polarization to the synapse (Fig. 6, 
B and C). DOCK8 mutant CD8 T cells also failed to polarize 
actin to the synapse, whereas polarization of PKC- occurred 
relatively normally (Fig. 6, D–G). Together these results in-
dicate that DOCK8 is required to form a normal T cell im-
mune synapse with antigen-presenting DCs.
DOCK8 is required for persistence of memory CD8 T cells
To  extend  the  aforementioned  results  and  examine  how 
DOCK8 mutation affects CD8 T cell clonal expansion and 
memory cell persistence in vivo after a viral challenge, OT-I 
T cells with either normal or defective DOCK8, distinguish-
able by CD45.1 and CD45.2 allelic markers, were mixed, and 
1,000 of each were cotransferred into normal C57BL/6 mice. 
survival over this time period (Fig. 5 B, bottom). We con-
clude that the persistence of naive peripheral CD8 T cells is 
intrinsically  decreased,  albeit  modestly,  when  they  lack 
normal  DOCK8.  Collectively  with  the  aforementioned 
normal thymocyte subsets, the reduced peripheral survival 
provides the simplest explanation for the 50% lower numbers 
of naive CD8 T cells at steady-state.
We asked whether the decrease in survival of naive CD8 
cells lacking normal DOCK8 was caused by a difference in 
the  expression  of  the    chain  of  the  receptor  for  IL-7, 
CD127, or in the T cell response to IL-7. Only a subtle but 
nevertheless consistent decrease in CD127 expression was 
observed on naive CD8 and CD4 T cells from Dock8pri/pri 
mice relative to WT littermates (Fig. S6). DOCK8 mutant 
CD8 and CD4 T cells responded to optimal concentrations 
of IL-7 in culture with indistinguishable short-term survival 
relative to WT controls (Fig. S7 A), although they did ex-
hibit a slight decrease in Bcl-2 induction under these condi-
tions (Fig. S7, B and C).
DOCK8 is required for LFA-1 polarization and rapid 
initiation of cell division
We next examined how DOCK8 deficiency affected CD8   
T cell activation. Naive CD8 T cells specific for ovalbumin 
peptide SIINFEKL presented by H2 Kb were purified from 
the spleens of OT-I TCR transgenic mice with WT or mutant 
DOCK8. The T cells were CFSE labeled and co-cultured 
with  SIINFEKL-pulsed  bone  marrow–derived  DCs,  and 
their cell division was followed over a time course by flow 
cytometry (Fig. 6 A). After 28 h, most of the WT cells had 
completed their first cell division, whereas few mutant cells 
had divided at this time point and only completed their first 
division by 34–40 h. Subsequent divisions nevertheless oc-
curred rapidly so that by 49 h there was little difference 
Figure 4.  Analysis of bone marrow chimeras. Bone 
marrow chimeras were reconstituted with 50% Dock8pri/pri 
CD45.2+ and 50% WT CD45.1+ bone marrow. Controls 
were reconstituted with 50% WT CD45.2 and 50% WT 
CD45.1 bone marrow. (A) Percentage of CD45.2+ cells re-
constituting the cellular subsets shown in these bone mar-
row chimeras. Each bar is the percent reconstitution of a 
cell subset in an individual mouse (indicated by the num-
ber below the bar). Data are representative of two inde-
pendent experiments. DN, double negative; DP, double 
positive. (B) Representative flow cytometry plots and 
quantitation of CD44 expression on CD45.2+ pri/pri and 
WT (+/+) cells from chimeras as in A. Bars are means, error 
bars indicate SEM, and dots indicate individual mice.2312 DOCK8 deficiency cripples CD8 T cells | Randall et al.
The DOCK8 mutant T cells clonally expanded almost as 
well as the normal controls in the same animals 7 d after the 
first viral challenge, although there was a subtle but consis-
tent decrease in each animal reproduced across many experi-
ments  (Fig.  7  B).  Thus,  the  mutant  OT-I  CD8  T  cells 
represented 35% of all donor-derived OT-I CD8 T cells in 
the spleen, peritoneal cavity, and bone marrow at day 7 after 
infection, compared with 45% of the donor cells at the time 
of adoptive transfer (Fig. 7 B, bottom). This result extends 
the aforementioned in vitro proliferation experiments and 
establishes that DOCK8 deficiency causes only a subtle de-
crease in the net proliferation of CD8 T cells in response to 
viral antigen in vivo.
By 28 d after the first viral challenge, when viral antigen 
had been cleared, the OT-I CD8 T cells with WT DOCK8 
had decreased in number in the spleen to 30% relative to 
their peak numbers at day 7 (Fig. 7 B). In contrast, DOCK8 
mutant OT-I T cells in the same animals decreased to 5% of 
their peak number so that they now represented only 10% of 
the overall donor-derived OT-I CD8 T cells (Fig. 7 B, 
bottom). When memory T cells against the virus and the   
SIINFEKL peptide were restimulated by a second viral in-
fection on day 35, both WT and DOCK8 mutant OT-I 
CD8 T cells increased in numbers relative to day 28. Despite 
this, the recall response by the mutant memory T cells was 
less so that they failed to reach the numbers of the first expo-
sure and accounted for only 5% of the OT-I CD8 T cells at 
the height of the recall response. The difference between the 
normal and DOCK8-defective T cells could not be explained 
by preferential movement of mutant OT-I cells into the bone 
marrow or peritoneum, as comparable differences occurred 
in the spleen, bone marrow, and peritoneum (Fig. 7 B). The 
possibility that Dock8pri/pri OT-I T cells were selectively re-
jected  because  of  minor  histoincompatibility,  either  as  a   
result of the DOCK8 mutation, other linked mutations, or the 
CD45.1 marker, was ruled out by performing parallel adoptive 
transfers with CD45.1 OT-I control cells that were either 
Dock8pri/+ heterozygous or WT (Fig. 7 C). The persistence 
and recall of both types of control OT-I T cells was equal to 
their cotransferred CD45.1/2 WT cells, whereas again there 
was greatly reduced persistence and recall of CD45.1 OT-I   
T cells that were homozygous for the Dock8 mutation.
Another possible explanation for the failure of DOCK8-
defective CD8 T cells to persist after antigen-induced clonal 
expansion would be that they selectively formed short-lived 
effector cells but not cells with the phenotypic markers of 
memory CD8 T cells. To investigate this possibility, we ex-
amined the expression of several markers of CD8 T cell acti-
vation  and  memory  cell  formation.  Surface  expression  of 
CD44, CD62L, CD127, and KLRG1 was indistinguishable 
between mutant and WT OT-I cells at all time points (Fig. 8 A), 
indicating that there was no measurable difference in the 
proportion of effector cells or absence of any phenotypically 
defined memory cell subsets to explain the failure of DOCK8 
mutant cells to persist. Slightly lower expression of Bcl2 
and Bim was observed in mutant OT-I cells on day 7 of the 
At the same time, the recipient mice were injected i.p. 
with a modified influenza virus that produces the SIINFEKL 
peptide incorporated within the neuraminidase stalk. Thus, 
the transferred OT-I T cells will receive help from, and com-
pete with, normal T cells recognizing other components of 
the virus in the recipient mice so that DOCK8 deficiency 
will be specifically limited to half of the transferred OT-I   
T cells. In addition to testing the cell-autonomous function 
of DOCK8 in CD8 T cells, any mouse to mouse variation in 
viral exposure or kinetics of the response could be internally 
controlled by directly comparing the ratio of the cotrans-
ferred OT-I T cells within a single animal. Primary and sec-
ondary viral challenges of the recipients were performed 
with  two  separate  influenza  strains,  H3N2  (HKx31)  and 
H1N1 (PR8), both expressing the SIINFEKL peptide, to re-
call memory CD8 T cell responses against the virus and the 
ovalbumin peptide without interference by neutralizing anti-
bodies against viral envelope proteins (Jenkins et al., 2006).
Flow cytometric analysis of lymphocytes from spleen, 
peritoneal cavity, and bone marrow was used to enumerate 
the transferred mutant and WT OT-I CD8 T cells (Fig. 7 A). 
Both DOCK8 mutant and WT OT-I CD8 T cells in-
creased >1,000-fold in response to viral antigen challenge. 
Figure 5.  Survival of naive Dock8pri/pri T cells. WT (CD45.1/CD45.2) 
and Dock8pri/pri (CD45.1) spleen cells were adoptively cotransferred into 
normal C57BL/6 mice (CD45.2). (A) Representative flow cytometry plots 
showing the percentage of adoptively transferred CD8 T cells at various 
time points after transfer. Numbers indicate the percentage of cells in the 
gate as a percentage of total spleen cells. (B) Quantitation of adoptively 
transferred CD8 T cells in two separate experiments using polyclonal  
T cells (top two panels) and one experiment using OT-I transgenic T cells 
(bottom). Data are representative of two separate experiments for each 
cell type. **, P < 0.01 for 2 test compared with input percentages.JEM Vol. 208, No. 11 
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a single cohort of recipient mice was followed longitudinally 
by measuring the transferred OT-I T cell frequency in their 
blood (Fig. 8 B). As before, there was only a subtle decrease 
in expansion of mutant OT-I T cells 7 d after the first viral 
exposure and a much more rapid decline of mutant T cells 
after this first antigen was cleared. However, by 195 d, the 
numbers of DOCK8-deficient OT-I T CD8 cells fell below 
the limit of reliable enumeration in all of the animals ana-
lyzed. In contrast, at the same time point, 
OT-I T cells with normal DOCK8 were 
still readily detected in the blood of three 
of the five recipient mice. In these animals, 
a large CD8 T cell recall response was made 
7 d after reexposure to SIINFEKL influ-
enza (day 202), with the numbers of OT-I 
T cells increasing 100-fold relative to day 
195 immediately before reexposure and 10-
fold relative to the peak of the primary re-
sponse on day 7. Although DOCK8 mutant 
T cells also increased in these animals, they 
comprised <1% of the secondary response. 
Thus, DOCK8 mutation in T cells causes 
only a subtle decrease in the initial virus- 
induced clonal expansion of CD8 T cells in 
vivo but severely compromises the long-
term persistence and recall of their memory 
CD8 progeny.
DISCUSSION
Our findings define a qualitative deficit in 
CD8 T cells caused directly by DOCK8 
deficiency.  Interpreting  the  consequences 
of DOCK8 mutation in CD8 T cells in 
primary influenza response, but this did not reach statistical 
significance in one of two experiments (not depicted).
To define the role of DOCK8 in the persistence and re-
call of memory CD8 T cells over longer time periods, the 
cotransfer of OT-I T cells with normal or defective DOCK8 
was repeated with a 6-mo delay between the primary H3N2 
and secondary H1N1 SIINFEKL influenza exposure. To di-
rectly relate the data from primary, memory, and recall phases,   
Figure 6.  Dock8pri/pri OT-I T cells show delayed 
proliferation and a defect in immune synapse 
formation in response to antigen presentation. 
(A) Naive WT and pri/pri splenic CD8 T cells were 
labeled with CFSE and cultured with SIINFEKL-
pulsed DCs. Cells were harvested at the indicated 
time points and analyzed for fluorescent intensity 
of CFSE by flow cytometry. Data are representative 
of five independent experiments. (B–G) Naive WT 
and pri/pri splenic CD8 T cells were co-cultured with 
preadhered SIINFEKL-pulsed DCs for 1 h and fixed 
for immunofluorescence staining. (B, D, and F) Tubu-
lin (red) staining was used to mark recruitment of 
the MTOC to the immune synapse along with 
costaining for the protein of interest (green). Images 
are representative of three independent experiments. 
Bars, 10 µm. (C, E, and G) Scoring of LFA-1 (+/+,  
n = 168; pri/pri, n = 176), actin (+/+, n = 70; pri/pri,  
n = 77), and PKC- (+/+, n = 50; pri/pri, n = 46) 
recruitment to the interface between the T cell  
and DC (marked by asterisks). Bars are mean, and 
error bars indicate SD. Scoring was performed blind 
as per Materials and methods. Statistical analysis was 
performed by the Student’s t test.2314 DOCK8 deficiency cripples CD8 T cells | Randall et al.
Our analysis has identified an important confounding fac-
tor, namely that many of the circulating CD8 T cells corre-
spond to a CD45RA+CCR7 exhausted TEMRA cell subset 
that is poorly responsive even in normal individuals. Further-
more, many of the CD45RA memory CD8+ T cells in 
these patients exhibited phenotypic and functional features 
of such exhausted cells. This phenotype is likely to reflect 
the repeated viral exposure faced by these patients, as has 
been observed in patients with other chronic infections such 
as late stage HIV (Chen et al., 2001; Brenchley et al., 2003) 
and patients with EBV-positive X-linked lymphoprolifera-
tive disease (Plunkett et al., 2005). We also found that 
DOCK8 deficiency in human T cells abrogated the robust 
DOCK8-deficient humans is complicated by their humoral 
immunodeficiency, varying degrees of lymphopenia, con-
current infections, and antibiotic and antiviral medication. 
Figure 7.  Pairwise analysis of persistence of Dock8pri/pri CD8 T cells 
after viral challenge. OT-I (V2+) T cells with either WT or mutant 
DOCK8 were mixed in a defined ratio and cotransferred into C57BL/6 
mice, which were then injected i.p. with modified influenza virus (first 
HKx31-SIINFEKL and then PR8-SIINFEKL), as indicated by the black  
arrows. (A) Representative flow cytometry plots showing identification of 
transferred cells at various time points. Control indicates no adoptive 
transfer. (B) Time course of adoptive transfer and infection. Graphs show 
numbers of transferred WT (open) and Dock8pri/pri (closed) cells at various 
time points within the same recipient mouse (top) and percentage contri-
bution of mutant cells to total donor cells within spleen (open), perito-
neum (closed), and bone marrow (striped; bottom). For the bottom panel, 
bars are means, and error bars indicate SEM. Data are representative of 
two independent experiments. (C) Adoptive transfers as in A and B with 
three experimental groups. Recipients were injected with Dock8pri/pri and 
WT (+/+) cells, Dock8pri/+ and WT (+/+) cells, or WT combined with WT 
cells. Graphs show numbers of transferred WT (open) and either Dock8pri/pri 
(left), Dock8pri/+ (middle), or WT (right panel; all closed) cells at various 
time points in the same recipient mouse.
Figure 8.  Further investigation of the consequences of DOCK8 
deficiency for persistence and recall of primed OT-I CD8 T cells. OT-I 
T cells with either WT or mutant DOCK8 were mixed in a defined ratio and 
cotransferred into C57BL/6 mice, which were then injected i.p. with modi-
fied influenza virus, as indicated by the black arrows. (A) Overlay histo-
grams of the expression of surface markers on WT (black) and Dock8pri/pri 
(red) donor and recipient (gray) CD8 T cells at the indicated time points 
after adoptive transfer. (B) Longitudinal time course of adoptive transfer 
and infection. Graphs show percentages of transferred WT (blue) and 
Dock8pri/pri (red) OT-I CD8 T cells in blood at various time points within the 
same recipient mouse (denoted by different symbols; top) and percent 
contribution of mutant cells to total donor cells at various time points 
after adoptive transfer (bottom). Bars are medians, and dots indicate indi-
vidual mice. Results of one independent experiment are shown.JEM Vol. 208, No. 11 
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OT-I T cells exhibited a persistence defect (70% decline in 
contribution to transferred OT-I cells over 21 d between 
days 7 and 28; Figs. 7 B and 8 B) that appears more severe 
than the survival defect exhibited by unstimulated OT-I cells 
bearing the mutation (50% decline in contribution to trans-
ferred OT-I cells over 39 d; Fig. 5 B). A subtle decrease in 
CD127 expression and IL-7–induced Bcl-2 was observed in 
DOCK8 mutant naive T cells and could theoretically explain 
the subtle decrease in their survival in vivo, but future studies 
will be needed to address how DOCK8 deficiency affects 
this pathway. The more dramatic decrease in memory CD8   
T cell survival was not accompanied by any measurable de-
crease in CD127 expression, and only a marginal decrease in 
Bcl-2. Elucidating the molecular pathway by which DOCK8 
promotes survival of naive and memory CD8 T cells and how 
this may relate to the synapse defect will be challenging given 
the many gaps in current understanding of the signals that in-
duce long-lived memory T cells. Regardless of its molecular 
basis, this intrinsic defect in naive and memory T cell persis-
tence coupled with uncontrolled viral infections provides an 
explanation for the markedly decreased frequency of circu-
lating naive CD8 T cells and the dramatic shift to CD8+ 
CD45RA+CCR7 TEMRA cells in DOCK8-deficient patients.
Although the experiments here establish that DOCK8 
deficiency causes a striking qualitative deficit in CD8 T cells, 
it is unlikely that the CD8 T cell defect alone accounts for the 
peculiar spectrum of viral infections and tissue-tropism seen in 
DOCK8 deficiency. Bone marrow transplantation resolved 
the cutaneous viral infections in two DOCK8-deficient pa-
tients, indicating that hematopoietic rather than epidermal 
defects are responsible (Bittner et al., 2010; Gatz et al., 2011). 
Deficiency of the skin-homing subset of CD8 T cells is un-
likely to explain the cutaneous infections because we find 
normal frequencies of skin-homing CD103+ CD8 T cells in 
the skin and gut of DOCK8 mutant mice (unpublished data), 
as well as in the circulation of DOCK8-deficient patients 
(unpublished data). It is significant that cutaneous infections 
with HSV, HPV, and M. contagiosum are much less prevalent 
in  severe  combined  immunodeficiency  or  selective  CD8   
T cell deficiency, indicating that the CD8 T cell defects de-
fined here are unlikely to be sufficient to explain the preva-
lence of these viral infections in DOCK8 deficiency (Laffort 
et al., 2004; Cerundolo and de la Salle, 2006; Notarangelo   
et al., 2009). Uncontrolled cutaneous infections with many 
of the same viruses are associated with evidence for greatly 
exaggerated Th2 cell activity in otherwise normal individuals 
with atopic dermatitis, asthma, and food allergy (Wollenberg 
et al., 2003; Beck et al., 2009). In this setting, Th2 cytokines 
are believed to suppress Th1 cells and IFN- production in 
the skin, thereby reducing control of these cutaneous viral 
infections by CD8 T cells and NK cells. Thus, it is attractive 
to speculate that in AR-HIES caused by DOCK8 deficiency, 
the effects of excessive Th2 cells interact with the qualitative 
defect in CD8 T cells to produce the severe HSV, M. conta-
giosum, and other skin viral infections. In contrast, autosomal 
dominant HIES (AD-HIES) caused by STAT3 mutations 
proliferative response observed for normal CD4 and CD8 
T cells after stimulation through the TCR and co-stimulatory 
molecules. This most likely reflects the advanced level of   
activation of these cells in vivo as a result of chronic pathogen 
exposure, which can cause extensive proliferation resulting 
in replicative senescence (Brenchley et al., 2003; Papagno 
et al., 2004). Indeed, a study of human CD8+ T cell subsets 
found that expression of CD57 correlates with impaired pro-
liferation and increased susceptibility to apoptosis in vitro 
(Brenchley et al., 2003). Similarly, CD8+ T cells that are 
CD57+ (Brenchley et al., 2003), CD57+CCR7CD27  
(Papagno et al., 2004), or CD45RA+CCR7CD27CD28 
(Rufer et al., 2003; Romero et al., 2007) have undergone the 
greatest levels of expansion in vivo, as determined by quanti-
tation of TCR excision circles or telomere lengths, yet fail to 
proliferate in vitro in response to TCR-mediated stimulation. 
Furthermore, exogenous cytokines failed to restore the pro-
liferative defect of CD57+CD8+ human T cells (Brenchley 
et al., 2003). Thus, the defects in proliferation of all DOCK8-
deficient CD8+ T cell subsets is consistent with an enrich-
ment in the frequency of CD57+CD27CD28 cells within 
both the memory and TEMRA cell subsets, as well as unusually 
high expression of CD95 by naive cells.
When DOCK8 deficiency was confined to a subset of the 
CD8 T cell repertoire in specific pathogen-free mice, we 
were able to establish an essential, intrinsic role for DOCK8 
in CD8 T cells that has its most dramatic effects on the per-
sistence  and  recall  of  antigen-stimulated  memory  CD8   
T cells. These effects, together with the effects of DOCK8 
deficiency on LFA-1 polarization at the CD8 T cell synapse 
and on initial entry into cell division, extend and translate to 
human immunity a growing body of evidence that normal CD8 
T cell memory depends on the quality of stimuli received 
through the T cell synapse before the first cell division.
DOCK8 was found not to be essential for thymic pro-
duction of T cells, with normal numbers of single-positive 
CD8 and CD4 cells, no evidence for a defect in CD8 cell–
positive selection in OT-I transgenic mice, and modest com-
petitive decreases in all thymic subsets in 50:50 chimeras. 
Although we have not directly measured thymic egress, there 
was no consistent evidence for either accumulation or defi-
ciency of mature CD69CD62L+ single-positive T cells in 
the thymus as occurs in animals with thymic egress defects 
(Matloubian et al., 2004; Carlson et al., 2006; Shiow et al., 
2008).  DOCK8  played  a  greater  role  in  peripheral  CD8   
T cells, with mutation of DOCK8 decreasing the number   
of naive T cells by 50%. The numbers of activated/memory 
CD44hi  CD8  T  cells  were  nevertheless  slightly  increased, 
presumably because these were sustained by antigen-driven 
or  homeostatic  proliferation  (Surh  and  Sprent,  2008).  In 
competitive bone marrow chimeras, 95% of the peripheral 
CD8 T cells were derived from the normal rather than the 
mutant bone marrow, and there was no relative shift toward 
CD44hi T cells among the DOCK8 mutant T cells. Cell trans-
fers show that DOCK8-deficient naive CD8 T cells persist less 
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resemble DOCK8-deficient OT-I cells more closely (Teixeiro 
et al., 2009). The TCR- mutation selectively interfered 
with clustering of the TCR and PKC- at the T cell synapse 
with antigen-presenting cells and the activation of NF-B. 
When the TCR- mutant OT-I T cells were adoptively 
transferred into mice infected with Listeria monocytogenes ex-
pressing ovalbumin antigen, the primary clonal expansion 
was comparable with normal OT-I T cells, but the mutant   
T cells subsequently declined more rapidly and made little 
recall expansion upon a second challenge (Teixeiro et al., 
2009). The behavior of Dock8pri/pri OT-I T cells most closely 
resembles normal CD8 OT-I T cells stimulated by ICAM-
1–deficient DCs (Scholer et al., 2008). Using normal and 
Icam1/ mice, Scholer et al. (2008) adoptively transferred 
normal OT-I T cells and then immunized them with anti-
DEC205 mAb coupled to ovalbumin with or without an-
tagonistic anti-CD40 mAb. Upon immunization, the primary 
clonal expansion of OT-I T cells was comparable in the two 
groups, but during the contraction phase, most of the OT-I 
T cells were lost in the Icam1/ mice, and little recall clonal 
expansion occurred upon rechallenge. Two-photon micros-
copy revealed a failure to form long-lived contacts between 
T cells and Icam1/ DCs, consistent with other evidence 
that prolonged contact with antigen is important for the for-
mation of CD8 memory T cells (Bachmann et al., 2006). 
Based on the findings here and studies of other DOCK pro-
teins (Côté and Vuori, 2007), DOCK8 deficiency in OT-I 
T cells may interfere with the inside-out signals needed to 
activate LFA-1 binding to ICAM-1 on DCs and to promote 
actin filaments that polarize LFA-1/ICAM-1 at the synapse.
The  similarities  between  the  effects  of  DOCK8  defi-
ciency, ICAM-1 deficiency, and TCR- mutation provide 
three independent lines of experimental evidence connecting 
the quality of the TCR synapse and the intracellular signals it 
generates with the persistence of memory CD8 T cells. Given 
the delay to first cell division caused by DOCK8 deficiency 
in  mice  and  the  impaired  proliferation  of  T  cells  from 
DOCK8-deficient patients, it is conceivable that qualitative 
differences in TCR signals are imprinted or stored in the   
T cell during the period leading up to the first cell division 
and then passed on silently through the rapid successive divi-
sions to become apparent only when the cells exit cycle and 
need to persist as nondividing memory cells (Mercado et al., 
2000; Kaech and Ahmed, 2001; van Stipdonk et al., 2001). 
Further analysis of DOCK8 deficiency in man and mouse 
will help to establish general principles for persistence of CD8 
T cell–mediated immunity, to guide new strategies for en-
hancing this arm of immunity in chronic viral diseases and can-
cer and for suppressing CD8 T cell memory in transplantation.
MATERIALS AND METHODS
Mice. Mice were housed in specific pathogen-free conditions, and all ex-
periments were approved by the Australian National University Animal 
Ethics and Experimentation Committee. Dock8pri/pri mice were generated as 
previously described (Randall et al., 2009). C57BL/6 and C57BL/6.SJL-
CD45.1 mice were obtained from Australian National University Bioscience 
Services. OT-I mice on the C57BL/6 background (Hogquist et al., 1994) 
results in mucocutaneous infections with Candida albicans 
and  cutaneous  infection  with  Staphylococcus  aureus  rather 
than uncontrolled viral infections. AD-HIES is associated with 
defective Th17 cells (de Beaucoudrey et al., 2008; Ma et al., 
2008; Milner et al., 2008; Renner et al., 2008) and perhaps 
other cell or cytokine defects, which result in this specific 
infectious susceptibility.
Patients  with  another  primary  immunodeficiency  that 
causes qualitative T cell abnormalities, Wiskott–Aldrich 
syndrome (WAS), share some clinical characteristics with 
DOCK8 immunodeficiency patients in that they have ec-
zema, a similar range of infections with M. contagiosum and 
papilloma and herpes viruses (Atherton et al., 2004), and ele-
vated levels of IgE (Bosticardo et al., 2009). The WAS pro-
tein is important for T cell synapse formation (Dupré et al., 
2002; Badour et al., 2003; Cannon and Burkhardt, 2004), 
and its expression in DCs is important for interactions be-
tween naive CD8 T cells and DCs (Pulecio et al., 2008). It 
had been previously assumed that the cutaneous infections 
in WAS were secondary to the eczema (Bosticardo et al., 2009), 
but the similarities between the clinical manifestations and 
cellular consequences of WAS protein and DOCK8 defi-
ciency support a link between susceptibility to these viral 
infections and the presence of a qualitative CD8 T cell syn-
apse defect. A similar spectrum of viral infections (papilloma-
virus and M. contagiosum) is also seen in epidermodysplasia 
verruciformis  (Casanova  and  Abel,  2007).  This  primary   
immunodeficiency occurs because of mutations in EVER1 
and EVER2 (Ramoz et al., 2002), disrupting zinc transport 
in keratinocytes, with increased zinc concentrations in the 
nucleus aiding papillomavirus replication (Lazarczyk et al., 2008). 
However, the molecular mechanism underlying suscepti-
bility to a similar spectrum of infections in DOCK8 defi-
ciency and EVER-1/2 deficiency is distinct because DOCK8 
patients do not have intrinsic abnormalities of their keratino-
cytes  as  bone  marrow  transplantation  has  been  associated 
with  resolution  of  chronic  viral  infections  (Bittner  et  al., 
2010; Gatz et al., 2011).
Although the initial clonal expansion of DOCK8-deficient 
OT-I CD8 T cells in response to influenza-produced antigen 
was almost equal to their paired OT-I WT T cells, the per-
sistence of mutant CD8 T cells after antigen was cleared was 
greatly diminished, and they exhibited poor secondary ex-
pansion upon reexposure to a CD8 T cell cross-reacting in-
fluenza strain. The preferential effect of DOCK8 mutation 
on the persistence and recall of CD8 memory T cells has 
parallels with several other studies (Williams et al., 2006b; 
Scholer et al., 2008; Teixeiro et al., 2009). Like DOCK8-
deficient CD8 T cells, IL-2Ra–deficient CD8 T cells also 
show normal primary expansion upon viral challenge in vivo 
but are greatly decreased in their secondary clonal expansion 
upon reexposure to antigen (Williams et al., 2006b). How-
ever, Il2ra deficiency differs because it does not accelerate 
the loss of antigen-specific CD8 T cells during the contrac-
tion phase after the primary response. OT-I T cells bear-
ing a mutation in the TCR -chain transmembrane domain JEM Vol. 208, No. 11 
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of 2 × 104 CFSE-labeled T cells/well. Cells were harvested at the indicated 
time points.
Immunofluorescence and confocal microscopy. For immunofluores-
cence staining, 2 × 104 naive splenic WT and pri/pri OT-I T cells/well were 
co-cultured with 3 × 104 SIINFEKL-pulsed bone marrow–derived DCs/
well in chamber slides (Oliaro et al., 2010). The cell conjugates formed were 
fixed at 1 h after incubation with fixative solution (100 mM Pipes, 5 mM 
MgSO4, 10 mM EGTA, 2 mM DTT, and 3.7% [wt/vol] paraformaldehyde, 
pH 7.0) for 10 min. The cells were then washed twice and incubated in per-
meabilization solution (PBS, 0.1% Triton X-100, and 0.5% BSA [wt/vol]) 
for 5 min before being washed and kept in blocking agent (PBS and 1% BSA 
[wt/vol]) overnight at 4°C. Primary antibodies against the proteins of inter-
est (anti–LFA-1 [BD], anti–PKC- [Santa Cruz Biotechnology, Inc.], and 
rhodamine-conjugated actin/phalloidin [Invitrogen]), together with mouse 
-tubulin (Rocklands) or rabbit -tubulin (Sigma-Aldrich), were added and 
incubated for 45 min at 4°C in the dark. Secondary antibodies (anti–rat and 
anti–rabbit Alexa Fluor 488 and anti–mouse and anti–rabbit Alexa Fluor 
546) were added after washing and incubated for another 45 min at 4°C in 
the dark. The cells were then washed and mounted in ProLong Gold anti-
fade reagent with DAPI (Invitrogen). Cells were imaged using a confocal 
microscope (Fluoview FV1000; Olympus) equipped with a 12.9-mW 488-nm 
multi-ion argon laser, a 1-mW 543-nm multi-ion green HeNe laser, and an 
11-mW 633-nm red HeNe laser. All images were captured using a Plan-
ApoN 60× oil immersion objective (NA = 1.42). The images were subse-
quently  processed  using  the  Olympus  Micro  FV10-ASW  program  and 
displayed as z-stack projections (sections = 0.5 µm). To acquire images in 
which an immune synapse was formed, conjugates with the MTOC (as 
marked by -tubulin) of T cells polarized to the interface with the DCs were 
chosen. Blinded scoring of the images was used as a means for quantifying 
the localization of proteins of interest. An integer score was given from   
3 (very polarized to the DC–T cell interface), to 0 (not polarized), to 3 
(very polarized away from the interface).
Chromium release killing assay. Splenocytes from C57BL/6 mice were 
pulsed with 1 µM SIINFEKL peptide for 2 h at room temperature before ir-
radiation at 6 Gy for 30 min. Splenocytes from WT or pri/pri OT-I mice 
were added to the irradiated C57BL/6 splenocytes with the addition of   
50 U/ml IL-2 and cultured for 5 d. DCs labeled with 100 µCi Cr51 were pulsed 
with SIINFEKL peptide for 1 h at 37°C. Activated WT and pri/pri OT-I 
splenocytes were added to the DCs at the indicated ratios and incubated at 
37°C for 4 h. Supernatant was collected and analyzed for chromium release 
by an automatic gamma counter (Wallac Wizard 1470; PerkinElmer).
T cell stimulation. Spleen cells from control and mutant mice were iso-
lated, red cells were lysed, and the cells were counted by trypan blue exclu-
sion. Three million cells (per milliliter in a 24-well plate) from each animal 
were cultured in the presence or absence of 25 ng/ml IL-7 (R&D Systems) 
with the complete tissue culture medium at 37°C and 5% CO2 for the indi-
cated time points. Cells were stained as in Flow cytometry of murine cells.
Human samples. Peripheral blood was collected from normal healthy do-
nors (Australian Red Cross Blood Service) and DOCK8-deficient patients 
(Table I). All human experiments were approved by the Sydney South West 
Area Health Service and St. Vincent’s Hospital Darlinghurst Human Re-
search Ethics Committees, as well as by the institutional review boards of the 
Necker Medical School, the Rockefeller University, and the National Insti-
tute of Allergy and Infectious Diseases (National Institutes of Health). For 
analysis,  the  following  mAbs  were  used:  FITC-conjugated  anti–human 
CCR7  (150503;  R&D  systems),  PerCP-Cy5.5–conjugated  anti–human 
CD45RA (HI100; eBioscience), PE-Cy7–conjugated anti-CD4 (SK3; BD), 
Pacific blue–conjugated anti–human CD8 (RPA-T8; BD), eFluor450- 
conjugated anti–human CD127 (eBioRDR5; eBioscience), PE-conjugated 
anti–human CD244 (2B4; Beckman Coulter, c1.7), PE-conjugated anti– 
human CD57 (HCD57; BioLegend), APC-human–conjugated anti-CX3CR1 
were provided by F. Carbone (The University of Melbourne, Parkville, Vic-
toria, Australia) and were crossed with Dock8pri/pri or Dock8+/+ B6.CD45.1 
mice to obtain OT-I transgenic offspring that were either Dock8pri/pri CD45.1 
homozygous or Dock8+/+ CD45.1/CD45.2 heterozygous.
Procedures. Bone marrow chimeras were generated as previously described 
(Randall et al., 2009). For adoptive transfers, C57BL/6 recipient mice were 
injected intravenously with 103 FACS-sorted OT-I CD8 T cells (50:50 mix-
ture of Dock8pri/pri CD45.1 homozygous and Dock8+/+ CD45.1/2 hetero-
zygous CD8 T cells). For influenza challenge experiments, the mice were 
also injected i.p. with H3N2 (A/HKx31) followed later by H1N1 (A/PR8) 
strains of recombinant influenza A viruses expressing SIINFEKL OVA257- 
264  (Jenkins  et  al.,  2006)  obtained  from  S.  Turner  (The  University   
of Melbourne).
Flow cytometry of murine cells. Single cell suspensions of spleen, LN, 
and bone marrow were obtained as described previously (Randall et al., 
2009). Data were acquired on a FACSCalibur (BD), FACS Sort (BD), or 
LSRII (BD) flow cytometer and analyzed using FlowJo software (Tree Star). 
The following antibodies were used for surface staining of lymphocytes for 
flow cytometry (from BD unless otherwise stated; clones indicated): FITC-
conjugated anti-CD4 (GK1.5), peridinin chlorophyll protein (PerCP)–cyanine 
(Cy) 5.5–conjugated anti-CD4 (RM4.5), PE-indotricarbocyanine (PE-Cy7)–
conjugated anti-CD4 (RM 4.5), allophycocyanin (APC)-conjugated anti-
CD4  (RM  4.5),  APC-Cy7–conjugated  anti-CD4  (GK1.5;  BioLegend), 
PE-conjugated  anti-CD4  (GK1.5),  PE-conjugated  anti-CD8a  (53–6.7), 
PerCPCy5.5-conjuated anti-CD8a (53-6.7), Alexa Fluor 405–conjugated 
anti-CD8a  (5H10;  Invitrogen),  APC–Alexa  Fluor  750–conjugated  anti-
CD8a (53-6.7, 5H10), PE-Cy7–conjugated anti-CD8a (53-6.7; BioLegend),   
APC-conjugated  anti-CD25  (PC61),  APC-Cy7–conjugated  anti-CD25 
(PC61; BioLegend), PE-conjugated anti-CD27 (LG.3A10), APC-conjugated 
anti-CD44  (1M7),  Alexa  Fluor  405–conjugated  anti-CD44  (1M7;   
Invitrogen), Pacific blue–conjugated anti-CD44 (IM7; BioLegend), PE-
conjugated anti-CD45.1 (A20), Alexa Fluor 700–conjugated anti-CD45.1 
(A20; BioLegend), Pacific blue–conjugated anti-CD45.2 (104; BioLegend), 
FITC-conjugated anti-CD45.2 (104), APC-conjugated anti-CD45.2 (104; 
eBioscience), FITC-conjugated anti-CD62L (MEL-14), APC-Cy7–conjugated 
anti-CD62L  (MEL-4;  BioLegend),  PerCPCy5.5-conjugated  anti-CD69 
(H1.2F3),  FITC-conjugated  anti-CD122  (5H4),  PE-indodicarbocyanine 
(PE-Cy5)–conjugated anti-CD127 (A7R34; eBioscience), PE-conjugated 
anti-CD152  (UC10-4F10-11),  FITC-conjugated  anti-B220  (RA3-6B2), 
APC–Alexa  Fluor  750–conjugated  anti-B220  (RA3-6B2;  Invitrogen), 
APC-conjugated  anti-KLRG1  (2F1;  eBioscience),  PE-conjugated  anti-
TCR V2 (B20.1), FITC-conjugated anti-CD45RB (16A), PE-conjugated 
anti-PD-1 (J43), and Alexa Fluor 700–conjugated CD3 (17A2; eBioscience). 
Cell viability was determined with 7 aminoactinomycin D (Invitrogen) and 
FITC-conjugated  anti–Annexin  V.  When  staining  using  Annexin  V,   
Annexin V binding buffer (BD) was used. For FACS sorting, splenocytes were 
stained with PE-conjugated anti-CD4 and FITC-conjugated anti-B220 as 
described above, and the negatively selected populations were harvested 
for the adoptive cell transfers. The following antibodies were used for   
intracytoplasmic  staining  of  lymphocytes:  PerCP-conjugated  anti-tbet 
(eBio4B10;  eBioscience),  FITC-conjugated  Bcl-2  (3F11),  and  Dylight-
conjugated  anti-Blimp  (3H2-E8).  Anti-Bim  (clone  3C5;  a  gift  from   
A. Strasser, Walter and Eliza Hall Institute of Medical Research, Parkville, 
Victoria, Australia) was conjugated to Alexa Fluor 647 using a Protein 
Labeling kit (A20173; Invitrogen).
CFSE proliferation. Splenic WT and pri/pri OT-I T cells were isolated 
using a MACS column negative selection kit (Miltenyi Biotech) according 
to the manufacturer’s protocol. Naive CD8 T cells were labeled with a final 
concentration of 5 µM CFSE as per Quah et al. (2007). Bone marrow–
derived DCs were derived as described previously (Oliaro et al., 2010) and 
seeded into 8-well chamber slides at 3 × 104 cells/well. They were then 
pulsed with SIINFEKL peptide for 1 h and washed twice before the addition 2318 DOCK8 deficiency cripples CD8 T cells | Randall et al.
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(2A9-1; BioLegend), APC-conjugated anti–human CD27 (O323; eBiosci-
ence),  PE-conjugated  anti–human  CD95  (DX2;  BD),  APC-conjugated 
anti–human  CD11a  (HI111;  BD),  PE-conjugated  anti–human  CD11b 
(D12; BD), APC-conjugated anti–human CD28 (CD28.2; BioLegend), PE-
conjugated anti–human perforin (dG9; eBioscience), and APC-conjugated 
anti–human Granzyme B (GB11; Invitrogen). CD4 and CD8 T cells were 
isolated from freeze thawed PBMCs using Dynal beads (Invitrogen) as per 
the manufacturer’s instructions. CD4+ T cells were labeled with anti-CCR7 
and anti-CD45RA mAbs and then sorted into naive and memory popula-
tions using a FACSAria (BD). Naive and memory CD4 T cells were isolated 
as CD45RA+CCR7+ and CD45RACCR7+/ cells, respectively, whereas 
naive and different central and effector memory CD8 T cells were isolated 
by sorting CD45RA+CCR7+, CD45RACCR7/+, and CD45RA+CCR7 
cells. CD4 and CD8 naive and memory T cell subsets were labeled with CFSE 
and cultured with TAE beads (one bead for every two cells; Miltenyi Bio-
tech) with or without 20 U/ml recombinant human IL-2 (Millipore) for 5 d. 
After this time, proliferation was determined by measuring CFSE dilution.
Data  analysis  and  statistics. Statistical analyses were performed using 
Prism software (GraphPad Software) or Excel (Microsoft). Statistical com-
parison was performed with unpaired Student’s t tests and 2 analysis as noted 
in the text.
Online supplemental material. Fig. S1 shows extended phenotypic analy-
sis of human DOCK8-deficient CD8+ T cells. Fig. S2 shows T cell counts 
in blood and LNs for Dock8pri/pri and C57BL/6. Fig. S3 shows that there is no 
evidence of an exhausted CD8 T cell phenotype in Dock8pri/pri and Dock8cpm/cpm 
mice. Fig. S4 compares T cell numbers in Dock8pri/pri, Dock8cpm/cpm, and C57BL/6 
mice. Fig. S5 shows further analysis of thymic subsets in Dock8pri/pri mice. 
Fig. S6 quantifies CD127 on the surface of T cell subsets from Dock8pri/pri and 
C57BL/6 mice. Fig. S7 shows survival of Dock8pri/pri and C57BL/6 T cells 
in culture with and without the addition of IL-7. Fig. S8 shows a chromium 
release assay using Dock8pri/pri OT-I T cells. Online supplemental material is 
available at http://www.jem.org/cgi/content/full/jem.20110345/DC1.
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